These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8663343

  • 1. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
    Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JK, Sun L, Brattain MG.
    J Biol Chem; 1996 Jul 19; 271(29):17366-71. PubMed ID: 8663343
    [Abstract] [Full Text] [Related]

  • 2. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
    Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JK.
    J Biol Chem; 1995 Sep 15; 270(37):22044-9. PubMed ID: 7665626
    [Abstract] [Full Text] [Related]

  • 3. Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells.
    Chen C, Wang XF, Sun L.
    J Biol Chem; 1997 May 09; 272(19):12862-7. PubMed ID: 9139748
    [Abstract] [Full Text] [Related]

  • 4. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK.
    Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532
    [Abstract] [Full Text] [Related]

  • 5. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.
    Sun L, Wu G, Willson JK, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG.
    J Biol Chem; 1994 Oct 21; 269(42):26449-55. PubMed ID: 7929366
    [Abstract] [Full Text] [Related]

  • 6. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P, Spang-Thomsen M, Poulsen HS.
    Br J Cancer; 1996 May 21; 73(9):1037-43. PubMed ID: 8624260
    [Abstract] [Full Text] [Related]

  • 7. Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells.
    Ammanamanchi S, Tillekeratne MP, Ko TC, Brattain MG.
    Cancer Res; 2004 Apr 01; 64(7):2509-15. PubMed ID: 15059906
    [Abstract] [Full Text] [Related]

  • 8. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB, Moody TW, You L, Mariano JM.
    Mol Carcinog; 1998 May 01; 22(1):46-56. PubMed ID: 9609100
    [Abstract] [Full Text] [Related]

  • 9. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
    Rodriguez C, Chen F, Weinberg RA, Lodish HF.
    J Biol Chem; 1995 Jul 07; 270(27):15919-22. PubMed ID: 7608141
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M, Oyasu R.
    Cell Growth Differ; 1997 Aug 07; 8(8):921-6. PubMed ID: 9269901
    [Abstract] [Full Text] [Related]

  • 11. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.
    Ammanamanchi S, Brattain MG.
    J Biol Chem; 2001 Aug 31; 276(35):32854-9. PubMed ID: 11443124
    [Abstract] [Full Text] [Related]

  • 12. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.
    Oncogene; 2000 Sep 21; 19(40):4660-7. PubMed ID: 11030155
    [Abstract] [Full Text] [Related]

  • 13. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P, Lindh G, Bergh A, Damber JE.
    Urol Res; 1999 Jun 21; 27(3):185-93. PubMed ID: 10422820
    [Abstract] [Full Text] [Related]

  • 14. Control of type II transforming growth factor-beta receptor expression by integrin ligation.
    Wang D, Sun L, Zborowska E, Willson JK, Gong J, Verraraghavan J, Brattain MG.
    J Biol Chem; 1999 Apr 30; 274(18):12840-7. PubMed ID: 10212271
    [Abstract] [Full Text] [Related]

  • 15. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
    Ko Y, Koli KM, Banerji SS, Li W, Zborowska E, Willson JK, Brattain MG, Arteaga CL.
    Int J Oncol; 1998 Jan 30; 12(1):87-94. PubMed ID: 9454891
    [Abstract] [Full Text] [Related]

  • 16. Cell-cycle-dependent expression of transforming growth factor beta type I receptor correlates with differential proliferative effects of TGFbeta1 in articular chondrocytes.
    Boumediene K, Félisaz N, Pujol JP.
    Exp Cell Res; 1998 Aug 25; 243(1):173-84. PubMed ID: 9716461
    [Abstract] [Full Text] [Related]

  • 17. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells.
    Periyasamy S, Sun L, Gentry LE, Brattain MG.
    J Cell Physiol; 1996 Sep 25; 168(3):711-20. PubMed ID: 8816926
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB, Moody TW, Mariano JM.
    Anticancer Res; 1997 Sep 25; 17(3C):1849-60. PubMed ID: 9216635
    [Abstract] [Full Text] [Related]

  • 19. Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells.
    Sun L, Chen C.
    J Biol Chem; 1997 Oct 03; 272(40):25367-72. PubMed ID: 9312157
    [Abstract] [Full Text] [Related]

  • 20. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
    Wang J, Sergina N, Ko TC, Gong J, Brattain MG.
    J Biol Chem; 2004 Sep 17; 279(38):40237-44. PubMed ID: 15271980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.